US Nasdaq stock alert

USA

CLOSING UPDATE: Amgen up 2.4% in 2 days 18 October 2017 17:52 EDT

NEWS BITES - NORTH AMERICA

This is an end of day Alert, produced after today's NASDAQ market close. It concludes the BSS News Bites intra-day Alert series (summaries below).

Amgen, NASDAQ's largest medical/biomedical company by market capitalisation, extended its gains on Wednesday, rising an additional 9.0c (or 0.05%) to trade at $US186.28. Trading volume was 71% of average at the end of the day. The shares have risen $US4.38 (or 2.4%) over the past two trading days vs. the NASDAQ-100 Index which has fallen 0.003% in the same period.

Technical indicators complementing today's significant uptrend:

+ The positive 0.72 MACD (Moving Average Convergence Divergence) indicator suggests a bullish signal.

+ The 2.5% discount to 12-month high of $US191.10 against the 40.3% premium to 12-month low of $US132.74 suggests the stock continues to push for new highs.

+ In the last three months the stock has hit a new 52-week high thrice.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Undervaluation:

+ Price/Earnings of 17.0 [30.7]

+ Dividend yield of 2.4% [0.8%]

+ Return on Equity 25.8% [18.9%]

Other Bullish Signals include:

+ The company is cash rich with Cash to Market Capitalisation at 25.6%.

+ Tobin's Q Ratio is 1.8. Compared with the rest of the market the stock is undervalued.

+ Net profit margin has averaged 30.4% in the last 3 years. This is considered superior and suggests a high margin of safety.

+ As per the Du Pont analysis, Return on Equity is high at 25.8%. Also, this has improved from 24.7% last year.

Note

The stock has outperformed 64% of the NASDAQ market over the past 6 months.

Bearish Signals:

The price decreased 0.1% in the last month.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Overvaluation:

Return on Capital Employed 13.8% [15.4%]

TODAY'S ALERT

Morning Alert: Amgen up 2.6% in 2 days

18 October 2017 11:04 EDT

Amgen Inc. (NASDAQ:AMGN) extended its gains on Wednesday, rising an additional 49.50c (or 0.3%) to trade at $US186.69. Trading volume was 1.8 times average so far today. The shares have risen $US4.79 (or 2.6%) over the past two trading days vs. the NASDAQ-100 Index which has risen 0.1% in the same period.

RECENT ALERTS

CLOSING UPDATE: Amgen lifts 2.4%, led NASDAQ Biotechnology higher

17 October 2017 17:54 EDT

Amgen, NASDAQ's largest medical/biomedical company by market capitalisation, has lifted 2.4% to trade at $US186.19 vs. the NASDAQ Biotechnology which strengthened 14.7 points (or 0.4%) to 3,541.9. Representing a weighting of about 13.4% of the index, the stock accounted for 75.1% of today's gain. Compared with the NASDAQ-100 Index which rose 8.1 points (or 0.1%) in the day, this represented a relative price increase of 2.2%.

Morning Alert: Amgen in 2nd consecutive fall, nears two-month low

17 October 2017 11:07 EDT

Amgen Inc. (NASDAQ:AMGN) slipped further on Tuesday, sliding an additional 21.0c (or 0.1%) to trade at $US181.69. The stock decreased 0.61% on Monday bringing its 2-day fall to 0.7%. It is now approaching its 38-day low of $US181.12.

Amgen Inc. (O:AMGN)

ISIN: US0311621009

PermID: 4295905537

CIK: 318154

CUSIP: 031162100

Source: www.BuySellSignals.com